Blog Posts
CenterWatch | Insights
Review of the FDA Draft Guidance: Considerations for Including Tissue Biopsies in Clinical Trials
Blog Posts
CenterWatch | Insights
Advancing Clinical Trials with AI
Blog Posts
CenterWatch | Insights
The FDA’s Guidance on Electronic Records and Signatures: Key Takeaways
Blog Posts
CenterWatch | Insights
The Role of AI in Regulatory Decision-Making for Drugs & Biologics: the FDA’s Latest Guidance
Blog Posts
CenterWatch | Insights
The FDA Accepts ICH E11A on Pediatric Extrapolation: How Does This Impact Your Pediatric Study?
Blog Posts
CenterWatch | Insights
How Do PIs Report PRI in a Blinded Study Without Unblinding Themselves?
Blog Posts
CenterWatch | Insights
Diversity in Clinical Research: Every Participant Counts
Blog Posts
CenterWatch | Insights
The Importance of Diversity in Clinical Trials and the Impact of FDA Guidance
Blog Posts
CenterWatch | Insights
Challenges and Innovations in Rare Disease in 2025
Blog Posts
CenterWatch | Insights